New Targeted Therapies Show Promise for Treating Advanced GIST
Two new targeted therapies have shown promise in patients with gastrointestinal stromal tumors (GIST) that have developed resistance to standard...
Two new targeted therapies have shown promise in patients with gastrointestinal stromal tumors (GIST) that have developed resistance to standard...
An NCI Cancer Currents blog post that provides an update on new content of interest to the cancer community recently...
A shorter course of chemotherapy following surgery may be preferred to longer treatment for some patients with colon cancer, results...
Researchers have created a long-sought-after mouse model for an aggressive form of acute lymphoblastic leukemia that occurs commonly in infants...
The FDA has approved rucaparib for women with BRCA-positive advanced ovarian cancer based on findings from two small clinical trials...
The targeted cancer therapy ibrutinib can effectively treat the symptoms of chronic graft-versus-host disease, a common and serious complication of...
NCI’s Dr. Mark Parascandola answers questions about The Economics of Tobacco and Tobacco Control, the latest in a series of...
The consumption of cigarettes, small cigars, and chewing tobacco has declined over the past 15 years, according to a new...
Fitness Article: Exercise with Lymphedema of the Leg… I am writing this article from two points of view, as an...
Powered by
